Objectives: Considering the crucial role of appropriate preventative strategies in reducing the rate of contrast induced nephropathy (CIN) occurrence and its related morbidity and mortality, the effect of N-acetylcysteine (NAC), Ascorbic Acid (AA) and normal Saline will be investigated in the patient’s undergone coronary angiography.
Design: In this randomized single blind, clinical trial,
Setting and conduct : 120 patients scheduled for elective coronary angiography with serum creatinine level more than 1.5mg/dl or GFR more than or equal 60 will be selected by convenience method and patients with Oliguria (<400cc/24hours), severe heart failure with left ventricular ejection fraction (LVEF) < 35%, contrast-agent hypersensitivity, pregnancy, lactation, acute renal failure, , Vitamin C supplements will exclude .
Intervention : Selected patients will be allocated in three treatment groups randomly to receive oral NAC(600mg/BID) plus normal saline (100ml/hour) [group A] ,oral ascorbic acid (250 mg/BID) plus normal saline (100ml/hour) [group B] and normal saline (100ml/hour) [group C], respectively.
Main outcome measures: Occurrence of CIN will be evaluated based of serum creatinine (Cr) and glomerular filtration rate (GFR) in three studied groups, before and 72hours after angiography procedure.